{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["26(7)"],"submitter":["Nevala W"],"funding":["Sorrento Therapeutics, Inc."],"journal":["International journal of molecular sciences"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11989481"],"repository":["biostudies-literature"],"pubmed_title":["PD-L1-Targeting Nanoparticles for the Treatment of Triple-Negative Breast Cancer: A Preclinical Model"],"pmcid":["PMC11989481"],"pubmed_authors":["Xie H","Stueven N","Nevala W","Geng L","Markovic S"],"additional_accession":[]},"is_claimable":false,"name":"PD-L1-Targeting Nanoparticles for the Treatment of Triple-Negative Breast Cancer: A Preclinical Model","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Apr","modification":"2025-06-26T03:05:52.17Z","creation":"2025-06-26T03:05:52.17Z"},"accession":"S-EPMC11989481","cross_references":{}}